Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis.
about
Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1Loss of Panx1 Impairs Mammary Gland Development at Lactation: Implications for Breast Tumorigenesis.Connexin and pannexin channels in cancer.Cx26 knockout predisposes the mammary gland to primary mammary tumors in a DMBA-induced mouse model of breast cancerRUNX1 and FOXP3 interplay regulates expression of breast cancer related genesAssociation of STAT3 with Cx26 and Cx43 in human uterine endometrioid adenocarcinomaGap junctions and cancer: communicating for 50 years.Localisation Microscopy of Breast Epithelial ErbB-2 Receptors and Gap Junctions: Trafficking after γ-Irradiation, Neuregulin-1β, and Trastuzumab Application.Cell communication across gap junctions: a historical perspective and current developments.Connexin 43 in the development and progression of breast cancer: What's the connection? (Review).Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections.Estrogen induces c-Kit and an aggressive phenotype in a model of invasive lobular breast cancer.Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration.The Complex Subtype-Dependent Role of Connexin 43 (GJA1) in Breast Cancer.The Novel Roles of Connexin Channels and Tunneling Nanotubes in Cancer Pathogenesis.Genetics: Transcribing for the enemy.
P2860
Q35530332-721CCE2B-06E5-4E2F-B4AC-9519D19C7426Q35995591-77F976D1-B39C-4898-9D40-243C3E78BACCQ36031173-4BE0DE14-2034-4B6C-A3D4-D3D942FE0D32Q36545695-7B29E31F-0FFF-4B0C-A5D0-879AE7913C9DQ36916273-2D4C87B6-7EE2-435E-9B8D-E5D9064E2301Q36954498-59EC0F5B-B996-497B-9425-755305E37C2BQ37613777-EB15A652-8AB7-40D8-BD47-E5B03181F17EQ37690877-B34F492F-A3A1-4238-BFC3-BF601E842B95Q38502080-54A393FD-5109-481D-809E-0AEFDBD8B9B8Q41389665-0AAD0F21-D991-4C81-8862-23F1A5A75E5EQ41619582-8DA928BE-0C69-499D-9AAB-308919E6FF00Q45073978-4D643783-F6D8-408E-8E55-D63A473DA1EEQ47220416-0AC2FBEF-FC0B-43F9-BC26-37A6E2CCFBB2Q52370671-142822AF-0CD4-4218-A52A-E482C41BC607Q52563269-7C8DE641-D5BE-459C-A810-ADD6537EC6A9Q54540610-16453904-19C3-4319-9F8C-74E3B35EE956
P2860
Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Correlations of differentially ...... cer progression and prognosis.
@ast
Correlations of differentially ...... cer progression and prognosis.
@en
Correlations of differentially ...... cer progression and prognosis.
@nl
type
label
Correlations of differentially ...... cer progression and prognosis.
@ast
Correlations of differentially ...... cer progression and prognosis.
@en
Correlations of differentially ...... cer progression and prognosis.
@nl
prefLabel
Correlations of differentially ...... cer progression and prognosis.
@ast
Correlations of differentially ...... cer progression and prognosis.
@en
Correlations of differentially ...... cer progression and prognosis.
@nl
P2093
P2860
P1433
P1476
Correlations of differentially ...... cer progression and prognosis.
@en
P2093
Attila Marcell Szasz
Gergo Kiszner
Ivett Teleki
Janina Kulka
Mate Elod Maros
Nora Meggyeshazi
Peter Balla
Tibor Krenacs
P2860
P304
P356
10.1371/JOURNAL.PONE.0112541
P407
P577
2014-11-10T00:00:00Z